Syneos Health, Inc.

DB:8IN Stock Report

Market Cap: €4.2b

Syneos Health Past Earnings Performance

Past criteria checks 1/6

Syneos Health has been growing earnings at an average annual rate of 34.5%, while the Life Sciences industry saw earnings growing at 27.3% annually. Revenues have been growing at an average rate of 6.4% per year. Syneos Health's return on equity is 2%, and it has net margins of 1.3%.

Key information

34.5%

Earnings growth rate

34.8%

EPS growth rate

Life Sciences Industry Growth26.8%
Revenue growth rate6.4%
Return on equity2.0%
Net Margin1.3%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Syneos Health makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:8IN Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 235,419716120
31 Mar 235,4141485690
31 Dec 225,3932665470
30 Sep 225,4072875590
30 Jun 225,4192785680
31 Mar 225,3402425740
31 Dec 215,2132355710
30 Sep 214,9802515420
30 Jun 214,7302365210
31 Mar 214,4611984840
31 Dec 204,4161934730
30 Sep 204,4891924640
30 Jun 204,5671874560
31 Mar 204,7201954590
31 Dec 194,6761315080
30 Sep 194,608864440
30 Jun 194,546174310
31 Mar 194,452194200
31 Dec 184,390244060
30 Sep 183,995-364340
30 Jun 183,472-1744260
31 Mar 182,658-1843680
31 Dec 171,853-1383140
30 Sep 171,365-862210
30 Jun 171,033891740
31 Mar 171,0331161740
31 Dec 161,0301131720
30 Sep 161,0091061710
30 Jun 169841161700
31 Mar 169521091640
31 Dec 159151171570
30 Sep 15887331540
30 Jun 1586081520
31 Mar 1583701490
31 Dec 14810-271450
30 Sep 14770131390
30 Jun 14732-11280
31 Mar 14687-271230
31 Dec 13652-421180
31 Dec 12579-601090

Quality Earnings: 8IN has a large one-off loss of $132.0M impacting its last 12 months of financial results to 30th June, 2023.

Growing Profit Margin: 8IN's current net profit margins (1.3%) are lower than last year (5.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 8IN has become profitable over the past 5 years, growing earnings by 34.5% per year.

Accelerating Growth: 8IN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 8IN had negative earnings growth (-74.4%) over the past year, making it difficult to compare to the Life Sciences industry average (12.2%).

Return on Equity

High ROE: 8IN's Return on Equity (2%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/09/28 15:50
End of Day Share Price 2023/09/27 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Syneos Health, Inc. is covered by 23 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gregory BolanAvondale Partners
Eric ColdwellBaird
Stewart GlickmanCFRA Equity Research